Table 3.
Demographic characteristics of the study population.
| Characteristic | ||
|---|---|---|
| Age in years | Mean ± SD | 60 ± 15 |
| Cancer type | n (%) | |
| Ovarian | 25 (50%) | |
| Uterine | 15 (30%) | |
| Cervical Vulvar Vaginal |
6 (12%) 2 (4%) 1 (2%) |
|
| Other/Unknown | 1 (2%) | |
| Race | n (%) | |
| White | 33 (66%) | |
| Black | 13 (26%) | |
| Asian | 0 (0%) | |
| 2 or more | 2 (4%) | |
| Unknown | 2 (4%) | |
| Comorbidities | n (%) Diabetes |
10 (20%) |
| Hypertension | 28 (56%) | |
| Obesity | 11 (22%) | |
| COPD | 4 (8%) | |
| Autoimmune disease | 3 (4%) | |
| Days since last chemo treatment | Median, range | 9, 3–45 |
| Length of hospital stay | Median, range | 4, 0–44 |
| Chemotherapy delays due to febrile neutropenia episode | n (%) | 15 (30%) |